Literature DB >> 16224936

The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference.

Richard M Bergenstal1, James R Gavin.   

Abstract

Self-monitoring of blood glucose (SMBG) is an underutilized but integral part of disease management for patients with both type 1 and type 2 diabetes. Guidelines on the recommended frequency and timing of SMBG vary among international diabetes associations, and patients are often unaware of actions they should take in response to SMBG. results. In response to this, a global consensus conference of recognized diabetes experts convened to clarify the role of SMBG as a tool to help optimize glycemic control (e.g., complementing information provided by hemoglobin A1c, detecting postprandial excursions, identifying glucose patterns, and providing patients feedback on lifestyle and medications) while minimizing hypoglycemia and maintaining quality of life. The consensus panel also sought to reinforce the importance of appropriate and systematic patient and provider response to the collected SMBG data. A set of 16 consensus statements was approved by the panel. This article presents the 16 statements together with some brief rationale for their inclusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224936     DOI: 10.1016/j.amjmed.2005.07.055

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  29 in total

1.  Benefits and limitations of self-monitoring of blood glucose.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2007-01

2.  Longitudinal study of new and prevalent use of self-monitoring of blood glucose.

Authors:  Andrew J Karter; Melissa M Parker; Howard H Moffet; Michele M Spence; James Chan; Susan L Ettner; Joe V Selby
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

Review 3.  Factors affecting blood glucose monitoring: sources of errors in measurement.

Authors:  Barry H Ginsberg
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

4.  Performance analysis of the OneTouch UltraVue blood glucose monitoring system.

Authors:  Anna Chang; Alice Orth; Bryan Le; Perla Menchavez; Lupe Miller
Journal:  J Diabetes Sci Technol       Date:  2009-09-01

5.  Self-adjustment of insulin dose using graphically depicted self-monitoring of blood glucose measurements in patients with type 1 diabetes mellitus.

Authors:  Andreas Reichel; Hannes Rietzsch; Barbara Ludwig; Katrin Röthig; Annette Moritz; Stefan R Bornstein
Journal:  J Diabetes Sci Technol       Date:  2013-01-01

Review 6.  Analytical Performance Requirements for Systems for Self-Monitoring of Blood Glucose With Focus on System Accuracy: Relevant Differences Among ISO 15197:2003, ISO 15197:2013, and Current FDA Recommendations.

Authors:  Guido Freckmann; Christina Schmid; Annette Baumstark; Malte Rutschmann; Cornelia Haug; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2015-04-14

7.  Lot-to-lot variability of test strips and accuracy assessment of systems for self-monitoring of blood glucose according to ISO 15197.

Authors:  Annette Baumstark; Stefan Pleus; Christina Schmid; Manuela Link; Cornelia Haug; Guido Freckmann
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

8.  System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197.

Authors:  Guido Freckmann; Christina Schmid; Annette Baumstark; Stefan Pleus; Manuela Link; Cornelia Haug
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

9.  What are the basic self-monitoring components for cardiovascular risk management?

Authors:  Alison M Ward; Carl Heneghan; Rafael Perera; Dan Lasserson; David Nunan; David Mant; Paul Glasziou
Journal:  BMC Med Res Methodol       Date:  2010-11-12       Impact factor: 4.615

Review 10.  Self-monitoring of blood glucose as part of the integral care of type 2 diabetes.

Authors:  Eleni I Boutati; Sotirios A Raptis
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.